335 related articles for article (PubMed ID: 28750627)
1. Air pollution exposure is associated with MRSA acquisition in young U.S. children with cystic fibrosis.
Psoter KJ; De Roos AJ; Wakefield J; Mayer JD; Rosenfeld M
BMC Pulm Med; 2017 Jul; 17(1):106. PubMed ID: 28750627
[TBL] [Abstract][Full Text] [Related]
2. Seasonality of acquisition of respiratory bacterial pathogens in young children with cystic fibrosis.
Psoter KJ; De Roos AJ; Wakefield J; Mayer JD; Rosenfeld M
BMC Infect Dis; 2017 Jun; 17(1):411. PubMed ID: 28599639
[TBL] [Abstract][Full Text] [Related]
3. Fine particulate matter exposure and initial Pseudomonas aeruginosa acquisition in cystic fibrosis.
Psoter KJ; De Roos AJ; Mayer JD; Kaufman JD; Wakefield J; Rosenfeld M
Ann Am Thorac Soc; 2015 Mar; 12(3):385-91. PubMed ID: 25594356
[TBL] [Abstract][Full Text] [Related]
4. Pan-Resistant Achromobacter xylosoxidans and Stenotrophomonas maltophilia Infection in Cystic Fibrosis Does Not Reduce Survival After Lung Transplantation.
Lobo LJ; Tulu Z; Aris RM; Noone PG
Transplantation; 2015 Oct; 99(10):2196-202. PubMed ID: 25856407
[TBL] [Abstract][Full Text] [Related]
5. Respiratory microbiology of patients with cystic fibrosis in the United States, 1995 to 2005.
Razvi S; Quittell L; Sewall A; Quinton H; Marshall B; Saiman L
Chest; 2009 Dec; 136(6):1554-1560. PubMed ID: 19505987
[TBL] [Abstract][Full Text] [Related]
6. Multicenter Observational Study on Factors and Outcomes Associated with Various Methicillin-Resistant Staphylococcus aureus Types in Children with Cystic Fibrosis.
Muhlebach MS; Heltshe SL; Popowitch EB; Miller MB; Thompson V; Kloster M; Ferkol T; Hoover WC; Schechter MS; Saiman L;
Ann Am Thorac Soc; 2015 Jun; 12(6):864-71. PubMed ID: 25745825
[TBL] [Abstract][Full Text] [Related]
7. Use of random amplified polymorphic DNA PCR to examine epidemiology of Stenotrophomonas maltophilia and Achromobacter (Alcaligenes) xylosoxidans from patients with cystic fibrosis.
Krzewinski JW; Nguyen CD; Foster JM; Burns JL
J Clin Microbiol; 2001 Oct; 39(10):3597-602. PubMed ID: 11574579
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes after initial pseudomonas acquisition in cystic fibrosis.
Zemanick ET; Emerson J; Thompson V; McNamara S; Morgan W; Gibson RL; Rosenfeld M;
Pediatr Pulmonol; 2015 Jan; 50(1):42-8. PubMed ID: 24644274
[TBL] [Abstract][Full Text] [Related]
9. Changing Epidemiology of the Respiratory Bacteriology of Patients With Cystic Fibrosis.
Salsgiver EL; Fink AK; Knapp EA; LiPuma JJ; Olivier KN; Marshall BC; Saiman L
Chest; 2016 Feb; 149(2):390-400. PubMed ID: 26203598
[TBL] [Abstract][Full Text] [Related]
10. Denitrification by cystic fibrosis pathogens - Stenotrophomonas maltophilia is dormant in sputum.
Kolpen M; Kragh KN; Bjarnsholt T; Line L; Hansen CR; Dalbøge CS; Hansen N; Kühl M; Høiby N; Jensen PØ
Int J Med Microbiol; 2015 Jan; 305(1):1-10. PubMed ID: 25441256
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics and epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in children with cystic fibrosis from a center with a high MRSA prevalence.
Harik NS; Com G; Tang X; Melguizo Castro M; Stemper ME; Carroll JL
Am J Infect Control; 2016 Apr; 44(4):409-15. PubMed ID: 26684366
[TBL] [Abstract][Full Text] [Related]
12. Investigation of Stenotrophomonas maltophilia epidemiology in a French cystic fibrosis center.
Capaldo C; Beauruelle C; Saliou P; Rault G; Ramel S; Héry-Arnaud G
Respir Med Res; 2020 Nov; 78():100757. PubMed ID: 32759054
[TBL] [Abstract][Full Text] [Related]
13. Association between Staphylococcus aureus alone or combined with Pseudomonas aeruginosa and the clinical condition of patients with cystic fibrosis.
Hubert D; Réglier-Poupet H; Sermet-Gaudelus I; Ferroni A; Le Bourgeois M; Burgel PR; Serreau R; Dusser D; Poyart C; Coste J
J Cyst Fibros; 2013 Sep; 12(5):497-503. PubMed ID: 23291443
[TBL] [Abstract][Full Text] [Related]
14. Airway infections as a risk factor for Pseudomonas aeruginosa acquisition and chronic colonisation in children with cystic fibrosis.
Mésinèle J; Ruffin M; Guillot L; Boëlle PY; Corvol H
J Cyst Fibros; 2023 Sep; 22(5):901-908. PubMed ID: 37422431
[TBL] [Abstract][Full Text] [Related]
15. [Bacterial isolates from respiratory samples of pediatric patients with cystic fibrosis and their distribution by ages].
Busquets NP; Baroni MR; Ochoteco MC; Zurbriggen ML; Virgolini S; Meneghetti FG
Rev Argent Microbiol; 2013; 45(1):44-9. PubMed ID: 23560788
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for emergence of Stenotrophomonas maltophilia in cystic fibrosis.
Talmaciu I; Varlotta L; Mortensen J; Schidlow DV
Pediatr Pulmonol; 2000 Jul; 30(1):10-5. PubMed ID: 10862157
[TBL] [Abstract][Full Text] [Related]
17.
Menetrey Q; Sorlin P; Jumas-Bilak E; Chiron R; Dupont C; Marchandin H
Genes (Basel); 2021 Apr; 12(5):. PubMed ID: 33919046
[TBL] [Abstract][Full Text] [Related]
18. Increasing Incidence of Multidrug Resistance Among Cystic Fibrosis Respiratory Bacterial Isolates.
Rutter WC; Burgess DR; Burgess DS
Microb Drug Resist; 2017 Jan; 23(1):51-55. PubMed ID: 27326758
[TBL] [Abstract][Full Text] [Related]
19. The cystic fibrosis lung microbiome.
Surette MG
Ann Am Thorac Soc; 2014 Jan; 11 Suppl 1():S61-5. PubMed ID: 24437409
[TBL] [Abstract][Full Text] [Related]
20. Review: Staphylococcus aureus and MRSA in cystic fibrosis.
Goss CH; Muhlebach MS
J Cyst Fibros; 2011 Sep; 10(5):298-306. PubMed ID: 21719362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
